How Tissue Repair, Regeneration, and Engineering will help in Plastic Surgery?
Technological
innovations in biotechnology and biomaterials have advanced rapidly over the
past decade. This is especially true in a new area of medicine called
regenerative medicine. Regenerative medicine is the replacement of damaged body
parts. The regenerative process includes a wide range of scientific discovery
and uses the latest techniques such as stem cell transplantation and artificial
tissues. This new field involves many medical subspecialties that include cell
biologists, biochemists, physicists, biomaterial engineers, geneticists,
nanotechnologists, and endocrinologists.
Through
extensive collaborations, clinicians and scientists are able to help a variety
of patients. One example is the use of tissue engineering to help patients who
have suffered tissue loss from burns, skin ulcers, decubitus ulcers, bone loss,
cartilage, or nerve damage. Another example is the use of synthetic materials
as dermal fillers to help patients reverse the signs of aging. The ability to
regenerate lost tissue such as skin has been made possible by advances in cell
biology. The discoveries of new growth factors and hormones have enabled us to
grow living human cells in tissue culture and still retain a high degree of
tissue function. Some of these tissues are grown on bioabsorbable scaffolds
seeded with cells and signaling molecules. This advance in cell growth has
enhanced our ability to grow many types of cells on tissue scaffolds.
Current
advances are the development of biocompatible biomaterials that will stimulate
new tissue in growth. The use of stem cells will allow the growth of particular
cell types. With this type of technology it is possible to trigger stem cells
to differentiate to skin, cartilage, tendons, bone, and many other tissues. The
discovery of embryonic stem cells derived from human fetal tissue, placentas,
or even fat cells from liposuction will become more important in the future for
these and other medical applications.
The
ability to incorporate new advances into patients' care is fundamental to the
science and art of plastic surgery. Plastic surgeons historically have used
autologous skin grafts to help with wound management. Since that time, great
progress has been made in the production of keratinocyte and epidermal grafts
(Epicel or autologous epidermal skin sheets) and bilayered (Integra artificial
skin, Dermagraft, Transcyte, Apligraf) skin substitutes. The pioneering work in
the area of tissue engineering of skin substitutes is the result of extensive
research and development in cell biology, collagen scaffolds, and biocompatible
tissue equivalents. This effort has resulted in injectable new biomaterials for
soft tissue augmentation and injectable or preformed scaffolds for hard tissueaugmentation. Plastic surgeons will be on the forefront of regenerative
medicine using new products for a variety of reconstructive and aesthetic
indications including improving rhytids and contour deformities and
reconstructing or augmenting bone and cartilage.
This
edition of Seminars in Plastic Surgery is dedicated to the use of such
biomaterials for these purposes. It contains a set of articles dealing with a
broad range of issues relevant to current practice. We are grateful to each
author who contributed to this issue of Seminars in Plastic Surgery. We
encouraged each to offer practical information that can be applied by all
plastic surgeons to enhance their practice and benefit our patients.
Comments
Post a Comment